Drawing for PRECEDE BIO INSIGHT

USPTO serial 99603645

PRECEDE BIO INSIGHT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BELL, MARLENE D
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with PRECEDE BIO INSIGHT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Caitlin R. Byczko

Caitlin R. Byczko Barnes & Thornburg LLP11 South Meridian StreetIndianapolis, IN 46204United States

Goods and services

ClassDescriptionStatusFirst use
005diagnostic assays and reagents for clinical and medical use, namely, for the testing of body fluids; diagnostic chemical, biochemical and biological preparations for medical purposes, namely, for treating and preventing cancers and other clinical pathologies; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancersACTIVE—
042Software as a service (SAAS) services featuring software for inputting, accessing, viewing, processing and analyzing medical data; data as a service (DAAS) services featuring non-downloadable software for the provision of data, namely, for inputting, accessing, viewing, processing and analyzing medical data; computer services, namely, providing data as a service (DaaS) services featuring non-downloadable software for analyzing and managing data for purposes of drug development and discovery; computer services, namely, the provision of data as a service (DaaS) services featuring software for use in the pharmaceuticals and healthcare fields for analyzing medical research data information in relation to pharmaceutical drug discovery and drug development; pharmaceutical research and development; pharmaceutical drug development and drug discovery services; medical research and scientific research; providing medical and scientific research information in the field of pharmaceuticals research and development of technology in the field of pharmaceuticals; biomedical research services; product development in the field of pharmaceuticals, namely, the development of preclinical and therapeutic productACTIVE—
044medical testing and diagnostic services; clinical pathology services, namely, medical pathology services; medical analysis services for diagnostic and treatment purposes relating to the treatment of persons in the nature of genomic and epigenomic profiling of human biological samples; medical testing for diagnostic or treatment purposes in the field of pathology relating to the treatment of persons; medical diagnostic testing, monitoring and reporting services; diagnostics services, namely, the recommendation of medical treatment for identified disease statesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 27, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 21, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 29, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 28, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 28, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Sep 28, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 28, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 24, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 24, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 24, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 10, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 10, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 10, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 26, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 26, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 26, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 17, 2026DOCKASSIGNED TO EXAMINER—
May 7, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 20, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 20, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance